<DOC>
	<DOC>NCT00002238</DOC>
	<brief_summary>To evaluate the safety and efficacy of interferon beta (Betaseron) in AIDS and advanced AIDS related complex (ARC) patients receiving a reduced-dose zidovudine (AZT) regimen.</brief_summary>
	<brief_title>Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Interferon beta-1b</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication: Allowed: Zidovudine (AZT). Patient must have: Uninterrupted therapy with reduceddose AZT 500 600 mg/day for at least 3 weeks before entry. Acceptable hepatic and renal function. AMENDED to delete the following sentence: Hematologic intolerance to fulldose zidovudine (AZT) (1000 1200 mg/day). Exclusion Criteria Coexisting Condition: Patients with the following are excluded: Concurrent, ineffectively controlled opportunistic infections. Extensive cutaneous and/or visceral Kaposi's sarcoma requiring systemic chemotherapy. Proteinuria of 2+ or greater. HIV encephalopathy. HIV wasting syndrome. New York Heart Classification III or IV. Uncontrolled angina pectoris. Evidence of clinically significant, multifocal uncontrolled cardiac dysrhythmias. Concurrent Medication: Excluded: Antiretrovirals other than zidovudine (AZT) or Betaseron. Chronic acyclovir therapy. Acetaminophen. Patients with the following are excluded: Intolerance (hematologic or otherwise) to zidovudine (AZT) at a dose of 100 mg orally every 4 hours. AMENDED to: Intolerance at a dose of 500 to 600 mg/day. Medical or psychiatric conditions that compromise the patient's ability to give informed consent or complete the study. Prior Medication: Excluded within 30 days of study entry: Cytotoxic chemotherapy. Prior therapy with alpha, beta, or gamma interferons. Active drug or alcohol abuse.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 1991</verification_date>
	<keyword>Drug Therapy, Combination</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Interferon Type I</keyword>
</DOC>